Cyanotriazoles activate latent HIV and strongly synergize with proteasome inhibitors ex vivo in resting CD4 T cells from suppressed HIV+ donors

• J. Murry,
• A. Tsai,
• M. Graupe,
• G. Jones,
• M. Tsiang,
• A. Arvey,
• L. Li,
• G. Stepan,
• H. Yu,
• T. Cihlar,
• D. Sloan,
• J. Lalezari

Affiliations

J. Murry

Gilead Sciences, Foster City, USA

A. Tsai

Gilead Sciences, Foster City, USA

M. Graupe

Gilead Sciences, Foster City, USA

G. Jones

Gilead Sciences, Foster City, USA

M. Tsiang

Gilead Sciences, Foster City, USA

A. Arvey

Gilead Sciences, Foster City, USA

L. Li

Gilead Sciences, Foster City, USA

G. Stepan

Gilead Sciences, Foster City, USA

H. Yu

Gilead Sciences, Foster City, USA

T. Cihlar

Gilead Sciences, Foster City, USA

D. Sloan

Gilead Sciences, Foster City, USA

J. Lalezari

Quest Clinical Research, San Francisco, CA, USA